Institut National De La Sante Et De La Recherche Medicale

Synthelabo

Agro Industrie Recherches Et Developpements A.r.d.

Edith Puchelle

Jean-Marie Zahm

Denis Pierrot

Aline Moreau

Rachid Benali

Anthony Bresin

Claude Galabert

Sophie Girod-Vaquez

Sophie Girod

Magali Milliot

Jean-Marie Zam

The present invention relates to the use of hyaluronic acid for the preparation of compositions intended for improving the protective function of the skin, the eye and the mucous membranes, in particular of the upper and lower airways and the intestinal mucosa.

Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes

EGF (Epidermal Growth Factor)-containing pharmaceutical composition and method for the treatment of bronchopulmonary pathologies accompanied by lesions of the bronchial epithelium utilising EGF.

EGF-containing pharmaceutical composition for the treatment of

Methods for treating disorders of the upper and lower airways, which disorders involve dehydration of the respiratory epithelium and hyperadhesion of mucus, using adenosine 5'-triphosphate disodium salt or uridine 5'-triphosphate, alone or in combination with amiloride.

Pharmaceutical compositions for the treatment of disorders of the

A composition for use in the treatment of the obstruction of air ways comprising one or more phospholipids, alone or in association with excipients. This composition can be used in a method of treating the obstruction of air ways in a patient.

Method of improving bronchial mucus transport

Growing community of inventors

Reims, France

Edith Puchelle